Bafna Pharmaceuticals Limited

NSE BAFNAPH.NS

Bafna Pharmaceuticals Limited Net Income for the year ending March 31, 2024: USD 880.94 K

Bafna Pharmaceuticals Limited Net Income is USD 880.94 K for the year ending March 31, 2024, a -36.14% change year over year. Net income is the total profit earned by a company after deducting all expenses, including taxes and non-controlling interest.

Bafna Pharmaceuticals Limited Net Income for the year ending March 31, 2023 was USD 1.38 M, a 100.80% change year over year.
Bafna Pharmaceuticals Limited Net Income for the year ending March 31, 2022 was USD 686.99 K, a -13.67% change year over year.
Bafna Pharmaceuticals Limited Net Income for the year ending March 31, 2021 was USD 795.75 K, a 124.25% change year over year.
Bafna Pharmaceuticals Limited Net Income for the year ending March 31, 2020 was USD -3.28 M, a -20.85% change year over year.

Key data

Date	Net Income	EPS (Diluted)	Shares (Diluted, Weighted)	Net Income Margin

NSE: BAFNAPH.NS

Bafna Pharmaceuticals Limited

CEO	Mr. Bansilal Mahaveer Chand Bafna
IPO Date	Nov. 12, 2012
Location	India
Headquarters	Bafna Towers
Employees	363
Sector	Healthcare
Industries Pharmaceuticals 3D Printing Cleaning Supplies Composite Materials Cosmetics Drugstores & Retail Pharmacies Glass Plastics

Description

Bafna Pharmaceuticals Limited manufactures and sells finished pharmaceutical formulations in India. The company provides delayed and sustained release, chewable, and orally disintegrating tablets. It also exports its products. Bafna Pharmaceuticals Limited was founded in 1981 and is based in Chennai, India.

Key trends

Past 5 years